Fale conosco

Nome *

Telefone

Empresa

E-mail *

Área *

Mensagem *

Search
1
33.5
18.75
Atlanta, EUA

Sede (Corporativo):

GranAPI LLC
255 Lenox Rd, NE#750,
Atlanta, GA 30326, USA

 

Biorefinarias:

Unidade Thomaston
300 McIntosh Parkway
Thomaston, GA 30286, USA

Unidade Alpena
412 Ford Avenue
Alpena, MI 19707, USA

1
74.75
30.75
São Paulo, Brasil

Sede

GranBio Investimentos S.A.
Av. Brig. Faria Lima, 2277, 15º andar, Conjunto 1503, Jd. Paulistano,
São Paulo, SP, CEP 01452-000, São Paulo, SP
+55 11 2739-0500

1
65.75
32.375
Alagoas, Brasil

Planta Industrial

BioFlex Agroindustrial.
Faz. São João, s/n – Zona Rural
57.249-899 – São Miguel dos Campos – AL – Caixa postal 14

Estação Experimental

Biovertis Produção Agrícola Ltda.
Fazenda Andorinha, Rod. AL 220 s/n, KM 6,5,
São Miguel dos Campos, Zona Rural, AL, CEP 57180-000

Telefones

Sede

+55 11 2739.0500

 

Press Releases

6 de Março de 2020 - PRESS RELEASE

GranBio Acquires 100% Equity of the North American Biotechnology Firm American Process Inc. (API)

The acquisition of American Process Inc’s technologies, intellectual property portfolio and physical assets strengthens GranBio’s market leading position in the deployment of highly competitive industrial processes for conversion of biomass to renewable fuels, chemicals, and nanocellulose.

GranBio completed the acquisition of 100% equity in American Process Inc. and affiliate companies including AVAPCO LLC and API Intellectual Properties Holdings. The acquired assets include the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in Thomaston, Georgia, operations, research, and business development staff and an extensive intellectual property portfolio in the biorefinery, biofuels, biochemicals, and nanocellulose fields with over 200 granted and pending patents.

“Acquiring the GreenPower+®, GreenBox+®, and AVAP® biorefinery technologies and the BioPlus® Nanocellulose Technology and their associated world-class demonstration plants and exceptional operations and R&D staff is part of GranBio’s mission to become a global leader in the bioeconomy. As evidenced by the construction and operation of the first commercial scale cellulosic ethanol plant in Brazil, GranBio is deeply committed to launching innovative biotechnologies that build a better and more environmentally safe planet for the next generations” said GranBio’s president, Bernardo Gradin.

About GranBio

GranBio is an industrial biotechnology company focused on commercial deployment of technologies for the production of biofuels, biochemicals, and advanced renewable materials including nanocellulose.

GranBio operates the first commercial scale cellulosic ethanol plant in the Southern Hemisphere. The biorefinery, named Bioflex 1, is located in Alagoas, Brazil and converts biomass from sugarcane residue, straw and bagasse into “second-generation” cellulosic ethanol.

Contact Information

Marcelo Lara
marcelo.lara@granbio.com.br
http://www.granbio.com.br

4703138767